A detailed history of Cwa Asset Management Group, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 29,219 shares of HRMY stock, worth $1.07 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
29,219
Previous 23,554 24.05%
Holding current value
$1.07 Million
Previous $781,000 18.18%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025

BUY
$27.94 - $35.91 $158,280 - $203,430
5,665 Added 24.05%
29,219 $923,000
Q1 2025

Apr 21, 2025

BUY
$32.18 - $40.46 $169,749 - $213,426
5,275 Added 28.86%
23,554 $781,000
Q4 2024

Jan 06, 2025

BUY
$31.86 - $41.49 $123,712 - $161,105
3,883 Added 26.97%
18,279 $628,000
Q3 2024

Nov 01, 2024

BUY
$30.0 - $39.95 $431,880 - $575,120
14,396 New
14,396 $575,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.17B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Cwa Asset Management Group, LLC Portfolio

Follow Cwa Asset Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.